» Articles » PMID: 6979516

Murine Respiratory Mycoplasmosis in F344 and LEW Rats: Evolution of Lesions and Lung Lymphoid Cell Populations

Overview
Journal Infect Immun
Date 1982 May 1
PMID 6979516
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

By comparison of two strains, LEW and F344, which are known to differ in susceptibility to Mycoplasma pulmonis respiratory disease, it was shown that differences in lesion severity and progression were associated with changes in lung lymphocyte populations. Lung lesions in LEW rats developed earlier after infection, became more severe, and were characterized by continued proliferation of all classes of lymphoid cells, T lymphocytes, B lymphocytes, and plasma cells, throughout the 120-day observation period. In contrast, lymphoid proliferation in F344 rats reached a plateau at 28 days and was restricted to an increase in T lymphocytes, immunoglobulin A (IgA)-bearing B lymphocytes, and IgA and IgG plasma cells. Although approximately 10 times as many IgG B cells and 4 times as many IgG plasma cells were found in infected LEW rats as compared with F344 rats, the specific anti-M. pulmonis IgG response in the two strains was roughly parallel. The same relationships held true, although to a lesser extent, for specific IgA antibody responses and cellular responses. Whereas lung lesions showed a tendency to resolve in F344 rats by 120 days, severe lesions persisted in LEW rats. The disparity between the cellular response and specific antibody response, the seemingly uncontrolled lymphocyte proliferation in LEW rats, and the mitogenic potential of M. pulmonis suggest that differences between LEW and F344 rats in lung lesion severity and progression are related to differences in the degree of nonspecific lymphocyte activation in the two strains, an imbalance in regulation of lymphocyte proliferation in LEW rats, or both.

Citing Articles

The Use of Bacteriophages and Immunological Monitoring for the Treatment of a Case of Chronic Septicemic Cutaneous Ulcerative Disease in a Loggerhead Sea Turtle Caretta caretta.

Greene W, Chan B, Bromage E, Grose J, Walsh C, Kortright K J Aquat Anim Health. 2021; 33(3):139-154.

PMID: 34216060 PMC: 8518602. DOI: 10.1002/aah.10130.


Molecular identification of Mycoplasma cynos from laboratory beagle dogs with respiratory disease.

Hong S, Kim O Lab Anim Res. 2012; 28(1):61-6.

PMID: 22474476 PMC: 3315197. DOI: 10.5625/lar.2012.28.1.61.


THE MULTIFACETED ROLE OF T CELL-MEDIATED IMMUNITY IN PATHOGENESIS AND RESISTANCE TO MYCOPLASMA RESPIRATORY DISEASE.

Dobbs N, Odeh A, Sun X, Simecka J Curr Trends Immunol. 2011; 10:1-19.

PMID: 21743780 PMC: 3131222.


Gender is a major factor in determining the severity of mycoplasma respiratory disease in mice.

Yancey A, Watson H, Cartner S, Simecka J Infect Immun. 2001; 69(5):2865-71.

PMID: 11292700 PMC: 98236. DOI: 10.1128/IAI.69.5.2865-2871.2001.


Infectious causes of chronic inflammatory diseases and cancer.

Cassell G Emerg Infect Dis. 1998; 4(3):475-87.

PMID: 9716980 PMC: 2640277. DOI: 10.3201/eid0403.980339.


References
1.
UHR J, Moller G . Regulatory effect of antibody on the immune response. Adv Immunol. 1968; 8:81-127. DOI: 10.1016/s0065-2776(08)60465-4. View

2.
Montfort I, Perez Tamayo R . Two antigenically different types of macrophages. Proc Soc Exp Biol Med. 1971; 138(1):204-7. DOI: 10.3181/00379727-138-35862. View

3.
Lindsey J, Baker H, Overcash R, Cassell G, Hunt C . Murine chronic respiratory disease. Significance as a research complication and experimental production with Mycoplasma pulmonis. Am J Pathol. 1971; 64(3):675-708. PMC: 2047606. View

4.
Werb Z, COHN Z . Plasma membrane synthesis in the macrophage following phagocytosis of polystyrene latex particles. J Biol Chem. 1972; 247(8):2439-46. View

5.
Katz D, Benacerraf B . The regulatory influence of activated T cells on B cell responses to antigen. Adv Immunol. 1972; 15:1-94. DOI: 10.1016/s0065-2776(08)60683-5. View